Propranolol and etodolac

DRUG3 trials

Sponsors

Sheba Medical Center, Assaf-Harofeh Medical Center

Conditions

Colorectal NeoplasmsPancreatic Neoplasms

Phase 2

Perioperative Intervention to Reduce Metastatic Processes in Pancreatic Cancer Patients Undergoing Curative Surgery

RecruitingNCT03838029

Assaf-Harofeh Medical CenterPancreatic Neoplasms

Start: 2019-11-20End: 2026-01-31Target: 210Updated: 2019-11-20

Colorectal Metastasis Prevention International Trial 2

RecruitingNCT03919461

Assaf-Harofeh Medical CenterColorectal Neoplasms

Start: 2019-02-28End: 2027-02-28Target: 200Updated: 2019-04-18

Phase 3

β-adrenergic Blocker and a COX2 Inhibitor for Prevention of Colorectal Cancer Recurrence

Sheba Medical CenterColorectal Neoplasms

Start: 2010-01-31End: 2017-01-31Target: 400Updated: 2011-07-12

Related Papers

Favorable safety outcomes of a perioperative propranolol and etodolac regimen in cancer patients in four randomized controlled trials

Frontiers in Pharmacology2026-04-20

β-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort.

2013-09-1952 citations